WANY
ENZ

Wealthspire Advisors (New York)’s Enzo Biochem, Inc. ENZ Stock Holding History

Wealthspire Advisors (New York)’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15,485
Closed -$43K – 839
2018
Q4 		$43K Buy
+15,485
New +$50.7K ﹤0.01% 207

Other funds holding ENZ

EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealthspire Advisors (New York)'s ENZ Position: Q1 2019 in Review

Wealthspire Advisors (New York) sold out of Enzo Biochem, Inc. (ENZ) in Q1 2019, closing a stake of 15,485 shares — an estimated $43K sold.

Wealthspire Advisors (New York) first reported a position in ENZ in Q4 2018 and held it in 1 quarter. The position peaked at $43K in Q4 2018. 85 funds tracked by Wall St. Rank hold ENZ as of Q1 2019.

  • Wealthspire Advisors (New York) reported no remaining Enzo Biochem, Inc. position as of Q1 2019 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 15,485 Enzo Biochem, Inc. shares in Q1 2019, an estimated $43K.
  • Wealthspire Advisors (New York) first reported a position in Enzo Biochem, Inc. in Q4 2018 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Enzo Biochem, Inc. position peaked at $43K in Q4 2018.
  • 85 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2019.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2019, filed 8 May 2019.